| Literature DB >> 26280501 |
Kar Wey Yong1,2, Wan Kamarul Zaman Wan Safwani1, Feng Xu2,3, Wan Abu Bakar Wan Abas1, Jane Ru Choi1,2, Belinda Pingguan-Murphy1.
Abstract
Mesenchymal stem cells (MSCs) hold many advantages over embryonic stem cells (ESCs) and other somatic cells in clinical applications. MSCs are multipotent cells with strong immunosuppressive properties. They can be harvested from various locations in the human body (e.g., bone marrow and adipose tissues). Cryopreservation represents an efficient method for the preservation and pooling of MSCs, to obtain the cell counts required for clinical applications, such as cell-based therapies and regenerative medicine. Upon cryopreservation, it is important to preserve MSCs functional properties including immunomodulatory properties and multilineage differentiation ability. Further, a biosafety evaluation of cryopreserved MSCs is essential prior to their clinical applications. However, the existing cryopreservation methods for MSCs are associated with notable limitations, leading to a need for new or improved methods to be established for a more efficient application of cryopreserved MSCs in stem cell-based therapies. We review the important parameters for cryopreservation of MSCs and the existing cryopreservation methods for MSCs. Further, we also discuss the challenges to be addressed in order to preserve MSCs effectively for clinical applications.Entities:
Mesh:
Year: 2015 PMID: 26280501 DOI: 10.1089/bio.2014.0104
Source DB: PubMed Journal: Biopreserv Biobank ISSN: 1947-5543 Impact factor: 2.300